- Time Warner Cable (TWC) was upgraded to outperform from market perform at Bernstein.
- Citigroup upgraded MEMC Electronic (WFR) and Skilled Healthcare (SKH) to buy from hold at Citigroup.
- Administaff (ASF) was upgraded to buy from hold at Roth Capital.
- The Buckle (BKE) was upgraded to buy from hold at KeyBanc.
- BofA/Merrill upgraded DreamWorks (DWA) to neutral from underperform.
- Corrections Corp. (CXW) was upgraded to buy from neutral at SunTrust.
- Marvell Technology (MRVL) was upgraded to positive from neutral at Susquehanna.
TCLP posts
FeedAnalyst Calls: ARO, BA, BKE, DWA, MRVL, SGEN, TWC, WFR ...
Continue reading Analyst Calls: ARO, BA, BKE, DWA, MRVL, SGEN, TWC, WFR ...
Analyst Calls: ALL, EMC, FCN, IRBT, JNPR, MRVL, RNOW, TRV, VRSN ...
Analyst Upgrades
- Oppenheimer upgraded VeriSign (VRSN) to outperform from perform, citing better-than-expected domain names trends and the potential for a sizeable share buyback. The firm has a $33 price target for shares.
- Oppenheimer also upgraded EMC (EMC) to outperform from perform, citing valuation and expectations for strong Q2 results. The firm set a $22 price target for shares.
- Piper Jaffray upgraded Juniper (JNPR) to overweight from neutral, citing valuation and its longer-term outlook. The firm keeps a $31 price target for shares.
- Kilroy Realty (KRC) was upgraded to neutral from underperform at BofA/Merrill.
- Veolia Environment (VE) was upgraded to buy from add at WestLB.
- QEP Resources (QEP) was upgraded to positive from neutral at Susquehanna.
Continue reading Analyst Calls: ALL, EMC, FCN, IRBT, JNPR, MRVL, RNOW, TRV, VRSN ...
Analyst upgrades, downgrades and initiations: ANN, AXP, CIEN, DE, RA, SBUX, ZION ...
- Jefferies upgraded Starbucks (SBUX) to buy from hold, citing EPS and revenue momentum heading into 2010. The firm raised its target to $25 from $22.
- Soleil upgraded Zions Bancorp (ZION) to buy from hold on valuation as it believes the recent pullback provides an attractive entry point. The firm has a $17.50 price target on shares.
- RBC Capital expects Rigel Pharmaceuticals (RIGL) to sign a partnership for R788 in the next four months to run its global Phase III program. Shares were upgraded to outperform from sector perform and its target was raised to $11 from $9.
- Deere (DE) was upgraded to overweight from equal weight at Morgan Stanley.
- Shire (SHPGY) was raised to outperform from market perform at Bernstein.
- Ann Taylor (ANN) was upgraded to overweight from market weight at Thomas Weisel.
- J.M. Smucker (SJM) was upgraded to overweight from neutral at JPMorgan.
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
Suddenly, Amazon Doesn't Love Its Moms Anymore



